These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 24096441)
1. Immunological screening for tumor cells in serous body fluids has added value with the CELL-DYN Sapphire. Keuren JF; Hoffmann JJ; Leers MP Clin Chem Lab Med; 2014 Feb; 52(2):253-8. PubMed ID: 24096441 [TBL] [Abstract][Full Text] [Related]
2. Analysis of serous body fluids using the CELL-DYN Sapphire hematology analyzer. Keuren JF; Hoffmann JJ; Leers MP Clin Chem Lab Med; 2013 Jun; 51(6):1285-90. PubMed ID: 23241681 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in serosal cavity fluids. Sayed DM; el-Attar MM; Hussein AA Diagn Cytopathol; 2009 Jul; 37(7):498-504. PubMed ID: 19217060 [TBL] [Abstract][Full Text] [Related]
4. An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions. Kentrou NA; Tsagarakis NJ; Tzanetou K; Damala M; Papadimitriou KA; Skoumi D; Stratigaki A; Anagnostopoulos NI; Malamou-Lada E; Athanassiadou P; Paterakis G Cytometry B Clin Cytom; 2011 Sep; 80(5):324-34. PubMed ID: 21695775 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of Epithelial Cell Adhesion Molecule Flow Cytometry for Diagnosis of Metastatic Carcinoma in Serous Effusions. Khodadadi N; Mokhtari M Acta Cytol; 2023; 67(3):265-272. PubMed ID: 36626892 [TBL] [Abstract][Full Text] [Related]
6. Flow cytometric quantification of intraperitoneal free tumor cells in patients with peritoneal metastasis. Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Kamei T; Yamashita H; Seto Y; Matsuzaki K; Watanabe T Cytometry B Clin Cytom; 2014 Jan; 86(1):56-62. PubMed ID: 24115348 [TBL] [Abstract][Full Text] [Related]
7. Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings. Risberg B; Davidson B; Dong HP; Nesland JM; Berner A J Clin Pathol; 2000 Jul; 53(7):513-7. PubMed ID: 10961174 [TBL] [Abstract][Full Text] [Related]
8. Flow cytometry in the detection of circulating tumor cells in neoplastic effusions. Gostomczyk K; Łukaszewska E; Borowczak J; Bator A; Zdrenka M; Bodnar M; Szylberg Ł Clin Chim Acta; 2024 Jan; 552():117651. PubMed ID: 37980974 [TBL] [Abstract][Full Text] [Related]
9. Subclassification of lymphoproliferative disorders in serous effusions: a 10-year experience. Tong LC; Ko HM; Saieg MA; Boerner S; Geddie WR; da Cunha Santos G Cancer Cytopathol; 2013 May; 121(5):261-70. PubMed ID: 23460311 [TBL] [Abstract][Full Text] [Related]
10. Detection of tumor cells in body cavity fluids by flow cytometric and immunocytochemical analysis. Krishan A; Ganjei-Azar P; Jorda M; Hamelik RM; Reis IM; Nadji M Diagn Cytopathol; 2006 Aug; 34(8):528-41. PubMed ID: 16850481 [TBL] [Abstract][Full Text] [Related]
11. A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies. Pillai V; Cibas ES; Dorfman DM Am J Clin Pathol; 2013 May; 139(5):672-81. PubMed ID: 23596119 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of flow cytometry in detecting malignant epithelial cells in serous effusions. Gaur G; Awasthi NP; Gupta A; Agarwal A; Sachan R; Malhotra KP; Shukla S; Singh AK; Singh P; Husain N J Am Soc Cytopathol; 2023; 12(6):423-435. PubMed ID: 37839931 [TBL] [Abstract][Full Text] [Related]
13. Serous effusions in malignant lymphomas: a review. Das DK Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559 [TBL] [Abstract][Full Text] [Related]
14. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions. Epenetos AA; Canti G; Taylor-Papadimitriou J; Curling M; Bodmer WF Lancet; 1982 Nov; 2(8306):1004-6. PubMed ID: 6127499 [TBL] [Abstract][Full Text] [Related]
15. Improvement of malignant serous effusions diagnosis by quantitative analysis of molecular claudin 4 expression. Mohamed F; Vincent N; Cottier M; Peoc'h M; Merrouche Y; Patouillard B; Paul S; Genin C Biomarkers; 2010 Jun; 15(4):315-24. PubMed ID: 20175704 [TBL] [Abstract][Full Text] [Related]
16. A new epithelial membrane antigen (Calam 27) as a marker of carcinoma in serous effusions. Gioanni J; Caldani C; Zanghellini E; Mazeau C; Duplay H; Ferrua B; Schneider M Acta Cytol; 1991; 35(3):315-9. PubMed ID: 2042433 [TBL] [Abstract][Full Text] [Related]
17. Cytology of body fluids from different sites: an approach for early diagnosis of malignancy. Pradhan SB; Pradhan B; Dali S JNMA J Nepal Med Assoc; 2006; 45(164):353-6. PubMed ID: 17676071 [TBL] [Abstract][Full Text] [Related]
18. Cytomorphology, clinicopathologic, and cytogenetics correlation of myelomatous effusion of serous cavities: A retrospective review. Harbhajanka A; Brickman A; Park JW; Reddy VB; Bitterman P; Gattuso P Diagn Cytopathol; 2016 Sep; 44(9):742-7. PubMed ID: 27434129 [TBL] [Abstract][Full Text] [Related]
19. Flow immunocytochemistry of marker expression in cells from body cavity fluids. Krishan A; Ganjei-Azar P; Hamelik R; Sharma D; Reis I; Nadji M Cytometry A; 2010 Feb; 77(2):132-43. PubMed ID: 19899128 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions. Passebosc-Faure K; Li G; Lambert C; Cottier M; Gentil-Perret A; Fournel P; Pérol M; Genin C Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6862-7. PubMed ID: 16203775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]